Приказ основних података о документу

dc.creatorKlisić, Aleksandra
dc.creatorŠćepanović, A.
dc.creatorKotur-Stevuljević, Jelena
dc.creatorNinić, Ana
dc.date.accessioned2022-06-16T08:40:15Z
dc.date.available2022-06-16T08:40:15Z
dc.date.issued2022
dc.identifier.issn1128-3602
dc.identifier.urihttps://farfar.pharmacy.bg.ac.rs/handle/123456789/4174
dc.description.abstractOBJECTIVE: To our knowledge, there are no studies that investigated the relationship between diabetes mellitus type 2 (T2D) and some novel indexes, such as monocyte/granulocyte to lymphocyte ratio (M/GLR), derived neutrophil to lymphocyte ratio (dNLR), and platelets to neutrophil ratio (PNR). The aim of this study was to examine the association between these novel indexes and glycated hemoglobin (HbA1c) in patients with prediabetes and T2D. PATIENTS AND METHODS: A total of 827 participants were consecutively recruited. According to the American Diabetes Association (ADA) criteria, participants were divided into control, prediabetes, and T2D group. RESULTS: White blood cell count (WBC), neutrophil count, NLR, dNLR, and M/GLR were higher in T2D patients than in the other two groups, whereas PNR was the lowest in T2D group. Lymphocyte count was higher in prediabetes and T2D patients than in control group. Multivariable ordinal regression analysis showed that WBC, neutrophil count, lymphocyte count, NLR, dNLR, and M/GLR were positively associated [OR (95% CI) 1.287 (1.191-1.390), p<0.001; 1.427 (1.275-1.594), p<0.001; 1.347 (1.130- 1.606), p=0.001; 1.350 (1.090-1.670), p=0.006; 1.662 (1.189-2.326), p=0.003; 1.275 (1.057-1.540), p=0.012, respectively] with HbA1c. However, PNR was negatively associated with HbA1c [0.987 (0.981-0.993), p<0.001]. CONCLUSIONS: Novel, modified NLR indexes, such as dNLR and M/GLR were independently correlated with HbA1c. Also, PNR showed superiority over platelets (PLT) in relation to HbA1c. These novel indexes might give a significant contribution to the timely recognition of disturbances of glucose homeostasis in patients with prediabetes and overt diabetes.
dc.publisherVerduci Editore srl
dc.relationinfo:eu-repo/grantAgreement/MESTD/inst-2020/200161/RS//
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceEuropean Review for Medical and Pharmacological Sciences
dc.titleNovel leukocyte and thrombocyte indexes in patients with prediabetes and type 2 diabetes mellitus
dc.typearticle
dc.rights.licenseBY-NC-ND
dc.citation.volume26
dc.citation.issue8
dc.citation.spage2775
dc.citation.epage2781
dc.citation.rankM22
dc.identifier.wos000795509000017
dc.identifier.doi10.26355/eurrev_202204_28607
dc.identifier.scopus2-s2.0-85129781048
dc.identifier.fulltexthttp://farfar.pharmacy.bg.ac.rs/bitstream/id/9879/Novel_leukocyte_and_pub_2022.pdf
dc.type.versionpublishedVersion


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу